Novel Targets for Treatment of Pseudomonas aeruginosa Biofilms - Antibiofilm Agents: From Diagnosis to Treatment and Prevention - page 261

Chaw KC et al (2005) Role of silver ions in destabilization of intermolecular adhesion forces
measured by atomic force microscopy in Staphylococcus epidermidis biofilms. Antimicrob
Agents Chemother 49(12):4853-4859
Chiang WC et al (2013) Extracellular DNA shields against aminoglycosides in Pseudomonas
aeruginosa biofilms. Antimicrob Agents Chemother 57(5):2352-2361
Chopra I (2007) The increasing use of silver-based products as antimicrobial agents: a useful
development or a cause for concern? J Antimicrob Chemother 59(4):587-590
Christensen LD et al (2012) Synergistic antibacterial efficacy of early combination treatment with
tobramycin and quorum-sensing inhibitors against Pseudomonas aeruginosa in an intraperito-
neal foreign-body infection mouse model. J Antimicrob Chemother 67(5):1198-1206
Ciofu O (2003) Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic
fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the
humoral immune response. APMIS Suppl(116): 1-47
Clatworthy AE et al (2007) Targeting virulence: a new paradigm for antimicrobial therapy. Nat
Chem Biol 3(9):541-548
Davies DG et al (1998) The involvement of cell-to-cell signals in the development of a bacterial
biofilm. Science 280(5361):295-298
Defoirdt T et al (2010) Can bacteria evolve resistance to quorum sensing disruption? PLoS Pathog
6(7):e1000989
Doring G et al (1986) Elastase from polymorphonuclear leucocytes: a regulatory enzyme in
immune complex disease. Clin Exp Immunol 64(3):597-605
El-Solh AA et al (2004) Colonization of dental plaques: a reservoir of respiratory pathogens for
hospital-acquired pneumonia in institutionalized elders. Chest 126(5):1575-1582
Emerson J et al (2002) Pseudomonas aeruginosa and other predictors of mortality and morbidity in
young children with cystic fibrosis. Pediatr Pulmonol 34(2):91-100
Fazli M et al (2009) Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus
aureus in chronic wounds. J Clin Microbiol 47(12):4084-4089
FitzSimmons SC (1993) The changing epidemiology of cystic fibrosis. J Pediatr 122(1):1-9
Fleiszig SM, Evans DJ (2002) The pathogenesis of bacterial keratitis: studies with Pseudomonas
aeruginosa . Clin Exp Optom 85(5):271-278
Frederiksen B et al (2006) Effect of aerosolized rhDNase (Pulmozyme) on pulmonary colonization
in patients with cystic fibrosis. Acta Paediatr 95(9):1070-1074
Fuqua WC et al (1994) Quorum sensing in bacteria: the LuxR-LuxI family of cell density-
responsive transcriptional regulators. J Bacteriol 176(2):269-275
Haagensen JAJ et al (2007) Differentiation and distribution of colistin- and sodium dodecyl
sulfate-tolerant cells in Pseudomonas aeruginosa biofilms. J Bacteriol 189(1):28-37
Hansen CR et al (2008) Early aggressive eradication therapy for intermittent Pseudomonas
aeruginosa airway colonization in cystic fibrosis patients: 15 years experience. J Cyst Fibros
7(6):523-530
Hardalo C, Edberg SC (1997) Pseudomonas aeruginosa : assessment of risk from drinking water.
Crit Rev Microbiol 23(1):47-75
Hawkey PM (2008) The growing burden of antimicrobial resistance. J Antimicrob Chemother 62
(Suppl 1):i1-i9
Hentzer M et al (2003a) Quorum sensing : a novel target for the treatment of biofilm infections.
BioDrugs 17(4):241-250
Hentzer M et al (2003b) Attenuation of Pseudomonas aeruginosa virulence by quorum sensing
inhibitors. EMBO J 22(15):3803-3815
Hoffmann N et al (2007) Azithromycin blocks quorum sensing and alginate polymer formation
and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas
aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. Antimicrob
Agents Chemother 51(10):3677-3687
Høiby N et al (2010) Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 35
(4):322-332